Gastrointestinal Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Endoscopy, Blood Test), By Technology, By Application, By Test Location, By Region, And Segment Forecasts, 2025 - 2030

Gastrointestinal Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Endoscopy, Blood Test), By Technology, By Application, By Test Location, By Region, And Segment Forecasts, 2025 - 2030


Gastrointestinal Diagnostics Market Growth & Trends

The global gastrointestinal diagnostics market size is expected to reach USD 6.56 billion by 2030, registering a CAGR of 4.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising awareness about gastrointestinal disorders and a surge in gastrointestinal disorder testing are the major factors driving the market. Moreover, technological advancements in gastrointestinal infection testing are expected to cater to the market demand. For instance, in May 2022, QIAGEN launched QIAstat-Dx Rise, which is capable of providing results in a span of one hour for multiple diseases.

The increasing trend of a sedentary lifestyle, lack of exercise, unhealthy eating habits, and a higher prevalence of obesity are anticipated to fuel GI diagnostics market growth. According to the CDC, the prevalence of obesity among people in the U.S. is between 30-40%. States such as Alabama, Alaska, and Arizona have the highest prevalence of obesity in the U.S. Obesity is associated with GI diseases such as gastroesophageal reflux disease, diarrhea, gastric cancer, and others. Hence, it is expected to impetus market growth.

Technological advancements associated with gastrointestinal diagnostics for early diagnosis and efficient testing are expected to augment market growth during the forecast period. For instance, in March 2022, Luminex Corporation obtained a CE mark for its NxTAGxMAP GI Pathogen Panel. This test is a detailed multiplex test that detects nucleic acids from the 16 most clinically relevant viral, parasitic, and bacterial pathogens in stool samples. Moreover, the test is capable of providing results on the same day and can run 96 samples at a time.

Moreover, the presence of organizations involved in increasing awareness regarding gastrointestinal disorders is expected to facilitate market expansion. For instance, organizations such as the Gastrointestinal Society (Canadian Society of Intestinal Research) and the International Foundation for Gastrointestinal Disorders are actively involved in promoting gastrointestinal health and broadening the understanding of GI disorders, thereby augmenting market growth.

Furthermore, various strategic initiatives undertaken by market players to strengthen their product portfolio and expand global footprints are likely to provide lucrative growth opportunities for the market. For instance, in November 2021, The Life Raft Group and Bayer Pharmaceuticals announced a research collaboration for broadening access to genomic testing for GI stromal tumor patients. The aim of this collaboration is to advance precision medicine and improve genetic testing to identify patients in the U.S.

In addition, in June 2021, Prometheus Laboratories, Inc. announced an agreement with MultiPlan for accessing specialized gastrointestinal testing. Prometheus offered its breakthrough testing solutions to improve the outcome of GI disorders. This agreement has allowed the testing service of Prometheus to reach the maximum number of customers.

Gastrointestinal Diagnostics Market Report Highlights
  • On the basis of test type, the endoscopy segment held the largest share in 2024 owing to rising demand for minimally invasive procedures
  • Based on technology, the PCR accounted for the second-largest share in 2024 due to the availability of a robust product portfolio and rising product launches
  • The infection application segment held the largest share in 2024 owing to the higher incidence of GI infections and the surge in awareness
  • On the basis of test location, the central laboratories segment held the largest share in 2024. The point-of-care segment is anticipated to register the fastest growth rate throughout the forecast period
  • Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing research activities in the region
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Delivery Mode outlook
2.2.3. Disease Area outlook
2.2.4. End Use outlook
2.3. Competitive Insights
Chapter 3. U.S. Telehealth Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Telehealth: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
Chapter 4. U.S. Telehealth Market Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. U.S. Telehealth Market, by Product, 2018 to 2030
4.5. Hardware
4.5.1. Hardware market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Monitors
4.5.2.1. Monitors market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3. Medical Peripheral Devices
4.5.3.1. Medical Peripheral Devices market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.2. Blood Pressure Meters
4.5.3.2.1. Blood Pressure Meters market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3. Blood Glucose Meters
4.5.3.3.1. Blood Glucose Meters market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.4. Weighing Scales
4.5.3.4.1. Weighing Scales market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.5. Pulse Oximeters
4.5.3.5.1. Pulse Oximeters market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.6. Peak Flow Meters
4.5.3.6.1. Peak Flow Meters market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.7. ECG Monitors
4.5.3.7.1. ECG Monitors market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.8. Others
4.5.3.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Software
4.6.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Standalone Software
4.6.2.1. Standalone Software market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.3. Integrated Software
4.6.3.1. Integrated Software market estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Services
4.7.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
4.7.2. Remote Patient Monitoring
4.7.2.1. Remote Patient Monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
4.7.3. Real-Time Interactions
4.7.3.1. Real-Time Interactions market estimates and forecasts, 2018 - 2030 (USD Million)
4.7.4. Store And Forward
4.7.4.1. Store And Forward market estimates and forecasts, 2018 - 2030 (USD Million)
4.7.5. Other Services
4.7.5.1. Other Services market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Telehealth Market Segment Analysis, By Delivery Mode, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Delivery Mode Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. U.S. Telehealth Market, by Delivery Mode, 2018 to 2030
5.5. On-Premises
5.5.1. On-Premises market estimates and forecasts, 2018 to 2030 (USD million)
5.6. Web-Based
5.6.1. Web-Based market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Cloud-Based
5.7.1. Cloud-Based market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. U.S. Telehealth Market Segment Analysis, By Disease Area, 2018 - 2030 (USD Million)
6.1. Definition and Scope
6.2. Disease Area Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. U.S. Telehealth Market, by Disease Area, 2018 to 2030
6.5. Psychiatry
6.5.1. Psychiatry market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Substance Use
6.6.1. Substance Use market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Radiology
6.7.1. Radiology market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. Endocrinology
6.8.1. Endocrinology market estimates and forecasts, 2018 - 2030 (USD Million)
6.9. Gastroenterology
6.9.1. Gastroenterology market estimates and forecasts, 2018 - 2030 (USD Million)
6.10. Dermatology
6.10.1. Dermatology market estimates and forecasts, 2018 - 2030 (USD Million)
6.11. Neurological Medicine
6.11.1. Neurological Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
6.12. ENT
6.12.1. ENT market estimates and forecasts, 2018 - 2030 (USD Million)
6.13. Cardiology
6.13.1. Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
6.14. Oncology
6.14.1. Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
6.15. Dental
6.15.1. Dental market estimates and forecasts, 2018 - 2030 (USD Million)
6.16. Gynecology
6.16.1. Gynecology market estimates and forecasts, 2018 - 2030 (USD Million)
6.17. General Medicine
6.17.1. General Medicine market estimates and forecasts, 2018 - 2030 (USD Million)
6.18. Others
6.18.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Telehealth Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2024 & 2030
7.3. Segment Dashboard
7.4. U.S. Telehealth Market, by End Use, 2018 to 2030
7.5. Payers
7.5.1. Payers market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Providers
7.6.1. Providers market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Patients
7.7.1. Patients market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. Koninklijke Philips N.V.
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. GE Healthcare
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Oracle (Cerner Corporation)
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Siemens Healthineers
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medtronic
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Teladoc Health Inc
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. American Well
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. MDLIVE
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Doctor on Demand
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. GlobalMed
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings